组织工程与重建外科杂志 ›› 2025, Vol. 21 ›› Issue (5): 508-.

• • 上一篇    下一篇

PIK3CA相关过度生长谱系病信号通路突变及相关靶向治疗研究进展

  

  • 出版日期:2025-10-13 发布日期:2025-10-30

Research progress of mutations in the signaling pathway of PIK3CA-related overgrowth spectrum disorders and related targeted therapy

  • Online:2025-10-13 Published:2025-10-30

摘要:

PIK3CA 相关过度生长谱系病(PROS)是一种血管畸形和身体某些部位节段性过度生长的罕见病,简称为PROS谱系疾病,所有疾病均由胚胎时期 PI3Kα亚基的基因突变所引起,进而影响 PI3K/AKT/mTOR 信号通路的改变并产生不同的表型。本文着重介绍了PROS突变的具体基因位点以及靶向PI3K/AKT/mTOR通路各种抑制剂的临床应用和疗效,同时论述了目前正在进行的各类临床试验及其未来前景,以推动创新疗法的开发和更精准的治疗策略的实施。

关键词:

Abstract:

PIK3CA-related overgrowth spectrum (PROS) disorders are rare diseases with vascular malformations and segmental overgrowth of certain body parts. These disorders, collectively referred to as the PROS spectrum, are all caused by mutations in the PIK3CA gene during embryonic development. These mutations lead to alterations in the PI3K/AKT/mTOR signaling pathway, resulting in diverse phenotypic manifestations. In this paper, the specific loci of PROS mutations and the clinical applications and efficacy of various inhibitors targeting the PI3K/AKT/mTOR pathway were reviewed, and the various ongoing clinical trials and their future perspectives were discussed, in order to promote the development of innovative therapies and the implementation of more precise treatment strategies.

Key words:

Targeted therapy